Advances in fertility-preservation surgery: navigating new frontiers

For female patients facing fertility-impairing treatment for select cancers and other medical conditions, fertility-preserving surgeries have evolved to meet the needs of those who desire fertility preservation. Over the last 70  years, advances in surgical options for fertility preservation have vastly increased in scope and availability. Major breakthroughs in fertility-preservation surgeries include the development of ovarian transposition procedures as well as uterine fixation; both procedures move these vital reproduc tive organs away from radiation fields to help protect and preserve future fertility.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Views and reviews Source Type: research

Related Links:

AbstractOvarian cancer starts in the ovaries in its earlier stages and then spreads to the pelvis, uterus, and abdominal region. The success of an ovarian cancer treatment depends on the stage of the cancer and the diagnostic system. Squamous cell carcinoma antigen (SCC ‐Ag) is one of the most efficient cancer biomarkers, and elevated levels of SCC‐Ag in ovarian cancer cells have been used to identify ovarian cancer. Carbon is a potential material for biosensing applications due to its thermal, electrical, and physical properties. Multiwalled carbon nanotubes ( MWCNTs) are carbon‐based materials that can be used here...
Source: Biotechnology and Applied Biochemistry - Category: Biochemistry Authors: Tags: Original Article Source Type: research
BOSTON (CBS) – Nearly 14,000 American women will die from ovarian cancer this year, but a new study from the UCHealth University of Colorado Hospital finds that women who use IUDs may be at lower risk. The symptoms of ovarian cancer can be mild or vague and there is no reliable screening test, so the diagnosis often isn’t made until it’s pretty advanced. But a new study of thousands of women around the world found that women who use intrauterine devices, or IUDs, for contraception may be 15-32% less likely to develop ovarian cancer. It’s not clear for how long they need to use one or why they may be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HealthWatch IUD Source Type: news
AbstractIntroductionTo assess the clinical impact of preoperative flourdeoxyglucose with positron emission tomography and computed tomography in women with ovarian ‐, fallopian tube‐, or peritoneal cancer with focus on consequences of added findings.Material and methodsFlourdeoxyglucose with positron emission tomography and computed tomography was implemented as a standard imaging modality for women with newly diagnosed ovarian, fallopian tube, or peritoneal cancer at our institution in 2008. After full implementation, all preoperative scans were reviewed and added findings were evaluated from January 2011 – Dece...
Source: Acta Obstetricia et Gynecologica Scandinavica - Category: OBGYN Authors: Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Cancer of a woman's reproductive organs is referred to as "gynecologic cancer." Dr. Amanika Kumar, a Mayo Clinic OB-GYN, says there are many forms of gynecologic cancer: endometrial or uterine, ovarian, vulvar, cervical, and vaginal. Watch: The Mayo Clinic Minute Journalists: Broadcast-quality video pkg (0:58) is in the downloads at the end of the post. [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
Abstract Hormone replacement therapy (HRT) remains the most effective treatment for menopausal symptoms and has been shown to prevent bone loss and fracture. The progestogen is added to provide endometrial protection in women with an intact uterus. After the publication of the initial WHI (Women's Health Initiative) results in 2002 reporting an overall increased risk of breast cancer, many women discontinued HRT. Despite the re-analysis of the results by subgroups of patients and updates with extended follow-up, much controversy remains, which we will analyze later in the text. Different types of estrogen or proge...
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Tags: Medicina (Kaunas) Source Type: research
We studied the expression of ARID1A, prostaglandin E2 synthase, and prostaglandin E2 receptor in the endometrium and ovarian, peritoneal, and intestinal endometrioid heterotopies in women with endometriosis of young and middle reproductive age. ARID1A protein is a tumor suppressor, its expression reduced in different types of cancer. Prostaglandin E2 synthase and prostaglandin E2 receptor are involved in the signaling cascade of inflammatory reactions presumably underlying the development of endometriosis. In endometrioid heterotopies, expression of ARID1A was reduced in 1.2-4.0 times, the expression of prostaglandin E2 sy...
Source: Bulletin of Experimental Biology and Medicine - Category: Biology Source Type: research
Conclusions: A close collaboration between Cancer and Fertility Center in a tertiary care hospital is essential to provide a good health service in oncological patients. Offering fertility preservation is no longer considered optional and must be included in every therapeutic program for women who receive an oncological diagnosis in their reproductive age. Oocyte cryopreservation is a good option for fertility preservation for women facing cancer treatment and our results, despite on a small sample, are encouraging. We also confirm a low utilization rate as only 4.5% of patients returned to use their gametes.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Conclusions: Between January and December 2018, 33 patients underwent surgery between two units. Indications for surgery included dysfunctional uterine bleeding, endometrial hyperplasia, pelvic pain, post-menopausal bleeding, prophylactic surgery in BRCA positive patients and one grade 1 stage 1 endometrial cancer in whom laparoscopic hysterectomy was technically difficult and complicated by previous midline laparotomy. Ages ranged from 35-75 and BMI from 20-53.Mean operation time was 68.5 minutes and mean blood loss intraoperatively was 269mls. 15.2% (n = 5) had a blood loss equal or more than 500&thi...
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
This article is protected by copyright. All rights reserved
Source: Biotechnology and Applied Biochemistry - Category: Biochemistry Authors: Tags: Original Article Source Type: research
CONCLUSIONS: The diagnosis and treatment of peritoneal serous papillary carcinoma may be delayed or may not be performed unless Class III findings are detected through uterine mucosal cytology before surgery. Surgeons should not hesitate to perform laparotomy when necessary to identify and appropriately treat patients, even if abnormalities are not detected in the preoperative examination. PMID: 31448396 [PubMed - in process]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Tokai J Exp Clin Med Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Ovarian Cancer | Ovaries | Reproduction Medicine